124 related articles for article (PubMed ID: 31934105)
1. EBV-associated myoid tumor with lipoblast-like cells in a patient with normal immunity.
Wu R; Tang W; Tang D; Li Y; Bian L; Li Y
Int J Clin Exp Pathol; 2019; 12(7):2733-2742. PubMed ID: 31934105
[TBL] [Abstract][Full Text] [Related]
2. Myoid neoplasm with lipoblast-like cells and haemangiopericytoma pattern: an unusual manifestation of EBV associated myoid tumour.
Cheng SKH; Yap WM; Chuah KL
Pathology; 2017 Jun; 49(4):435-438. PubMed ID: 28438391
[No Abstract] [Full Text] [Related]
3. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC
Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
6. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma.
Granato M; Rizzello C; Romeo MA; Yadav S; Santarelli R; D'Orazi G; Faggioni A; Cirone M
Int J Biochem Cell Biol; 2016 Oct; 79():393-400. PubMed ID: 27620077
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and Epstein-Barr virus infection status of Burkitt's lymphoma in Guangzhou district.
Huang YH; Wu QL; Zong YS; Feng YF; Liang JZ; Hou JH; Shao Q; Fu J
Ai Zheng; 2009 Aug; 28(8):805-12. PubMed ID: 19664325
[TBL] [Abstract][Full Text] [Related]
8. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum.
Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA
Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
Renouf B; Hollville E; Pujals A; Tétaud C; Garibal J; Wiels J
Leukemia; 2009 Sep; 23(9):1557-63. PubMed ID: 19421231
[TBL] [Abstract][Full Text] [Related]
11. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
D'Souza B; Rowe M; Walls D
J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
14. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
16. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
17. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature.
Rogatsch H; Bonatti H; Menet A; Larcher C; Feichtinger H; Dirnhofer S
Am J Surg Pathol; 2000 Apr; 24(4):614-21. PubMed ID: 10757411
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG
Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537
[TBL] [Abstract][Full Text] [Related]
20. Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA(EBER) in situ hybridization.
Engel PJ
APMIS; 2000 Jun; 108(6):393-7. PubMed ID: 11028801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
